Population‐level management of type 1 diabetes via continuous glucose monitoring and algorithm‐enabled patient prioritization: Precision health meets population health
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To develop and scale algorithm-enabled patient prioritization to improve population-level management of type 1 diabetes (T1D) in a pediatric clinic with fixed resources, using telemedicine and remote monitoring of patients via continuous glucose monitor (CGM) data review. RESEARCH DESIGN AND METHODS: We adapted consensus glucose targets for T1D patients using CGM to identify interpretable clinical criteria to prioritize patients for weekly provider review. The criteria were constructed to manage the number of patients reviewed weekly and identify patients who most needed provider contact. We developed an interactive dashboard to display CGM data relevant for the patients prioritized for review. RESULTS: The introduction of the new criteria and interactive dashboard was associated with a 60% reduction in the mean time spent by diabetes team members who remotely and asynchronously reviewed patient data and contacted patients, from 3.2 ± 0.20 to 1.3 ± 0.24 min per patient per week. Given fixed resources for review, this corresponded to an estimated 147% increase in weekly clinic capacity. Patients who qualified for and received remote review (n = 58) have associated 8.8 percentage points (pp) (95% CI = 0.6-16.9 pp) greater time-in-range (70-180 mg/dl) glucoses compared to 25 control patients who did not qualify at 12 months after T1D onset. CONCLUSIONS: An algorithm-enabled prioritization of T1D patients with CGM for asynchronous remote review reduced provider time spent per patient and was associated with improved time-in-range.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Estimation and Inference of Heterogeneous Treatment Effects using Random Forests
Wager, S., & Athey, S. (2018) · Journal of the American Statistical Association · doi:10.1080/01621459.2017.1319839 · Cited by 2,917 · cited 1×
“depends on the patients' state; to further control for this effect, we fit a propensity model of contact and estimated the effects of contacts using a causal forest model (Appendix).(19)”
MethodShanafelt, T. D., Dyrbye, L. N., Sinsky, C., Hasan, O., Satele, D., Sloan, J., & West, C. P. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.05.007 · Cited by 1,086 · cited 1×
“In order to facilitate efficient care delivery for patients using CGM, clinics need help analyzing large amounts of CGM data and limiting the total review time required of providers.(10) Data science and algorithm design have the potential to direct attention to the patients most likely to benefit from provider contac…”
BackgroundGood intentions are not enough: how informatics interventions can worsen inequality
Veinot, T. C., Mitchell, H., & Ancker, J. S. (2018) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy052 · Cited by 704
Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0022 · Cited by 400
Addala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., Walker, A., Rosenbauer, J., Maahs, D. M., & Holl, R. W. (2021) · Diabetes Care · doi:10.2337/dc20-0257 · Cited by 283 · cited 1×
“Gaps in diabetes technology use and patient outcomes are further exacerbated by structural racial and socioeconomic disparities.(6,7) Clinics seeking to expand access to their telemedicine program, especially to underserved populations geographically separated from pediatric endocrinologists; stand to benefit from eff…”
BackgroundSelf-citationPhillip, M., Bergenstal, R. M., Close, K. L., Danne, T., Garg, S. K., Heinemann, L., Hirsch, I. B., Kovatchev, B. P., Laffel, L. M., Mohan, V., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0375 · Cited by 135 · cited 2×
“Data science and algorithm design have the potential to direct attention to the patients most likely to benefit from provider contact and to fill existing technical deficiencies to enable the Digital Diabetes Clinic.(11,12) Many tools exist to analyze CGM data for an individual patient.”
BackgroundKumar, R. B., Goren, N. D., Stark, D. E., Wall, D. P., & Longhurst, C. A. (2016) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocv206 · Cited by 126
The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes
Fonda, S. J., Graham, C., Munakata, J., Powers, J. M., Price, D., & Vigersky, R. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816628547 · Cited by 81
Cited by
Prahalad, P., Ding, V. Y., Zaharieva, D. P., Addala, A., Johari, R., Scheinker, D., Desai, M., Hood, K., & Maahs, D. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab859 · Cited by 82
Self-citationA New Technology-Enabled Care Model for Pediatric Type 1 Diabetes
Scheinker, D., Prahalad, P., Johari, R., Maahs, D. M., & Majzun, R. (2022) · NEJM Catalyst · doi:10.1056/cat.21.0438 · Cited by 25
Self-citationCrossen, S. S., Romero, C. C., Lewis, C., & Glaser, N. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1063290 · Cited by 22
Metadata
- Authors
- Ferstad, J. O., Vallon, J. J., Jun, D., Gu, A., Vitko, A., Morales, D. P., Leverenz, J., Lee, M. Y., Leverenz, B., Vasilakis, C., Osmanlliu, E., Prahalad, P., Maahs, D. M., Johari, R., & Scheinker, D.
- Venue
- Pediatric Diabetes
- Publisher
- Wiley
- Published
- 2021-09
- Volume
- 22
- Issue
- 7
- Pages
- 982-991
- ISSN
- 1399-543X (ISSN-L)
- 1399-5448
- OpenAlex
- W3162523004
- Cited by
- 46
- References
- 9
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.